Unfortunately, I have another round of layoffs and cutbacks to announce. Takeda has been talking about rearranging its R&D for months now, and they’re finally gotten around to it. Their operations in the UK are getting hit particularly hard, as the company says that Shonan, Japan and Boston will be their two major R&D sites.
That’s also bad news for their site in Chicago, where I’m told that a large part of the staff is being laid off, with some being offered a move to Boston. Some there are also being offered positions as part of a new CRO arrangement (but that, of course, entails a large cut in benefits, etc.) The company’s San Diego site has also seen layoffs, going well up into management. And even thought the Boston site is going to be the company’s US flagship, I’m hearing of a number of layoffs there, too, although these (from the sound of it) are less in management and more directed at bench scientists. . .